Lawrence M Shuer, MD
Neurosurgery · Stanford
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 14
- 3 carriers
- Office
- 1
Offices
1 location · Stanford Health Care · 3,152 clinicians in this group
Looking this up.
Hospitals listed: Stanford Health Care. That is not proof they admit you there this week.
Plans that list them
14 plans · 3 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Shuer’s office at (650) 723-4000 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
14 of 14 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Anthem Full Dual Advantage Aligned (HMO D-SNP) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
California Medical Board record
Licence G39747 · Current
Licensed to practise in California · since 1979 · expires 2027-04-30 · University of Michigan Medical School.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for Stanford Health Care
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.31 (4.24 to 6.37) · 8,661 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 14.1 (12.7 to 15.7) · 2,191 cases | Worse | Jan 2024 – Dec 2024 |
| Postoperative respiratory failure rateComplications and deaths | 4.08 (1.95 to 6.21) · 5,296 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.317 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.446 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.241 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.7 (0.6 to 0.9) · 3,348 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.06 (0.45 to 1.67) · 5,374 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.86 (0.72 to 1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 166.09 (137.88 to 194.3) · 470 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.1 · 192 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.4 · 146 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.7 · 253 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 6.3 · 880 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 935 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 501 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.1 · 7,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.13 (0 to 0.27) · 20,799 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.14 to 0.43) · 23,182 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.94 (0.2 to 1.68) · 5,694 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.36 (1.54 to 3.19) · 7,846 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.2 (3.76 to 6.64) · 5,603 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.38 (0.23 to 2.53) · 2,211 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.52 (0.21 to 0.83) · 19,915 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.6 · 416 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.869 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.857 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.368 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16.2 · 247 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.5 · 1,021 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 47.8 · 258 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -1.6 · 990 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 20.8 · 976 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.5 · 959 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (4.4 to 6.2) · 2,191 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 425 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.6 · 158 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 183 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.7 (10.4 to 15.4) · 4,578 cases | No different | Jan 2022 – Dec 2024 |
What patients said (6,810 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 82% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 79% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 83% |
| Staff "always" explained possible side effects | 50% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$56,681
Medicare paid this office $56,681 for 190 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 75 | $7,890 | $77 |
| New patient visit (45+ min) | 63 | $6,855 | $109 |
| New patient visit (60+ min) | 16 | $2,613 | $163 |
| Short return visit (20+ min) | 14 | $1,181 | $79 |
| Electronic analysis of implanted neurostimulator generator with complex cranial nerve stimulator programming | 12 | $508 | $42 |
Procedures Medicare counted
| Laminectomy or laminotomy (partial removal of spine bones) | 1-10 | None |
| Spinal fusion | 1-10 | None |
Who their Medicare patients are
190 Original Medicare patients in 2024. Average age 71 · Under 65 17% · 85 and older 14% · Women 57% · Also on Medicaid 31% · Health risk score 1.25. At or below the middle of the specialty; the typical neurosurgery clinician is at 1.46.
Conditions among them: High blood pressure 71% · Diabetes 31% · Depression 28% · Coronary heart disease 26% · Chronic kidney disease 21% · Stroke 18% · Cancer 15% · Atrial fibrillation 14% · Heart failure 11% · COPD 8% · Dementia 8%.
The office billed $284,046, Medicare allowed $74,239 and paid $56,681; for 337 services of 31 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 190 | 337 | 71 | 1.25 | $284,046 | $56,681 |
| 2023 | 214 | 385 | 73 | 1.29 | $388,971 | $74,825 |
| 2022 | 220 | 449 | 71 | 1.29 | $498,042 | $92,367 |
| 2021 | 213 | 370 | 71 | 1.31 | $414,567 | $79,104 |
| 2020 | 180 | 320 | 71 | 1.36 | $296,847 | $55,655 |
| 2019 | 212 | 363 | 70 | 1.34 | $358,505 | $66,360 |
| 2018 | 231 | 432 | 70 | 1.31 | $423,902 | $79,668 |
| 2017 | 220 | 437 | 69 | 1.16 | $476,422 | $88,977 |
| 2016 | 219 | 415 | 69 | 1.21 | $601,602 | $100,522 |
| 2015 | 207 | 360 | 69 | 1.21 | $461,306 | $80,919 |
| 2014 | 199 | 333 | 66 | 1.24 | $430,771 | $84,960 |
| 2013 | 213 | 385 | 69 | 1.30 | $430,618 | $80,713 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 5 services
| Return visit (30+ min) | 89 | $8,890 | $85 |
| New patient visit (45+ min) | 79 | $8,443 | $107 |
| Short return visit (20+ min) | 31 | $1,952 | $54 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 18 | $1,361 | $76 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 14 | $1,005 | $46 |
2022: 5 services
| Return visit (30+ min) | 95 | $10,101 | $80 |
| New patient visit (45+ min) | 69 | $7,920 | $115 |
| Short return visit (20+ min) | 42 | $2,446 | $54 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 14 | $1,153 | $35 |
| New patient visit (30+ min) | 14 | $577 | $41 |
2021: 3 services
| New patient visit (45+ min) | 86 | $10,016 | $116 |
| Return visit (30+ min) | 91 | $9,502 | $80 |
| Short return visit (20+ min) | 26 | $1,300 | $48 |
2020: 4 services
| Return visit (30+ min) | 44 | $3,432 | $66 |
| Short return visit (20+ min) | 68 | $3,204 | $38 |
| New patient visit (45+ min) | 25 | $3,013 | $121 |
| New patient visit (30+ min) | 27 | $1,672 | $62 |
2019: 4 services
| Short return visit (20+ min) | 95 | $4,782 | $39 |
| New patient visit (30+ min) | 68 | $4,207 | $62 |
| Return visit (30+ min) | 32 | $2,512 | $68 |
| New patient visit (45+ min) | 15 | $1,706 | $114 |
2018: 7 services
| Short return visit (20+ min) | 94 | $4,783 | $39 |
| New patient visit (45+ min) | 23 | $2,502 | $109 |
| New patient visit (30+ min) | 38 | $2,447 | $64 |
| Return visit (30+ min) | 30 | $2,190 | $66 |
| Short return visit (20+ min) | 35 | $1,613 | $45 |
| Return visit (30+ min) | 13 | $918 | $71 |
| New patient visit (30+ min) | 14 | $884 | $63 |
2017: 6 services
| Short return visit (20+ min) | 125 | $6,869 | $39 |
| New patient visit (30+ min) | 68 | $3,767 | $55 |
| Use of operating microscope | 14 | $2,552 | $182 |
| Return visit (30+ min) | 25 | $1,652 | $64 |
| New patient visit (45+ min) | 11 | $1,040 | $95 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 11 | $777 | $65 |
2016: 5 services
| Short return visit (20+ min) | 115 | $6,523 | $43 |
| New patient visit (30+ min) | 74 | $5,397 | $73 |
| Use of operating microscope | 11 | $2,012 | $183 |
| New patient visit (45+ min) | 15 | $1,457 | $97 |
| Return visit (30+ min) | 13 | $932 | $72 |
2015: 5 services
| Return visit (30+ min) | 59 | $4,466 | $64 |
| New patient visit (45+ min) | 41 | $4,036 | $98 |
| Short return visit (20+ min) | 75 | $3,553 | $42 |
| New patient visit (30+ min) | 40 | $2,721 | $68 |
| Use of operating microscope | 11 | $2,027 | $184 |
2014: 4 services
| New patient visit (45+ min) | 71 | $7,975 | $112 |
| Return visit (30+ min) | 67 | $4,715 | $64 |
| Short return visit (20+ min) | 59 | $2,563 | $39 |
| Use of operating microscope | 13 | $2,361 | $182 |
2013: 4 services
| New patient visit (45+ min) | 80 | $8,594 | $107 |
| Return visit (30+ min) | 88 | $6,529 | $62 |
| Short return visit (20+ min) | 54 | $2,369 | $36 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 13 | $1,434 | $110 |
Money from drug and device companies
$174 in 2025
| 2025 | 2 | 3 | None | $174 |
| 2024 | 2 | 2 | None | $125 |
| 2021 | 1 | 1 | $30 | $30 |
| 2020 | 1 | 1 | $490 | $490 |
| 2019 | 2 | 2 | None | $194 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
ARKIS BIOSCIENCES INC
$21,342
Held by this doctor · 2019 · Total Options Vested, Option Holder
Published ownership or investment in a drug or device company. This is not proof that care is biased.
A payment is not proof that care is biased.
| LivaNova USA | Vns Therapy Sentiva Model 1000 Generator | $138 | 2 payments
|
| Davol | Avitene Ultrafoam | $36 | 1 payment
|
See all 3 published payments
| Davol | Meals · 2025-12-16 | Avitene Ultrafoam | $36 |
| LivaNova USA | Meals · 2025-09-17 | Vns Therapy Sentiva Model 1000 Generator | $21 |
| LivaNova USA | Meals · 2025-09-17 | Vns Therapy Sentiva Model 1000 Generator | $116 |
See earlier years (2024, 2021, 2020, 2019)
2024: $125
| Medtronic | Percept PC Brainsense | $67 | 1 payment
|
| Medexus Pharma | Gleolan | $59 | 1 payment
|
2021: $30
| Medtronic | Midas Rex | $30 | 1 payment
|
2020: $490
| ZOLL Medical | None | $490 | 1 payment
|
2019: $194
| Stryker | Cascadia | $140 | 1 payment
|
| NeuroPace | Rns System | $54 | 1 payment
|
Research money
Money a company paid to run a study. Where it went to their institution, the clinician is named as an investigator and did not receive it; the amount covers the whole study, often across many sites.
| Integra LifeSciences Corporation · A Prospective, Multicenter Study To Evaluate the Performance and Safety of the Cerebroflo Evd Catheter · 2025 | Their institution | $43,648 |
| Integra LifeSciences Corporation · A Prospective, Multicenter Study To Evaluate the Performance and Safety of the Cerebroflo Evd Catheter · 2024 | Their institution | $27,786 |
| Orthofix Medical, Inc. · M6-C Artificial Cervical Disc Ide Post Approval Study · 2022 | Their institution | $20,360 |
| Orthofix Medical, Inc. · M6-C Post Approval Study (Pas) · 2021 | Their institution | $15,200 |
| Integra LifeSciences Corporation · A Prospective, Multicenter Study To Evaluate the Performance and Safety of the Cerebroflo Evd Catheter · 2022 | Their institution | $14,995 |
| Integra LifeSciences Corporation · A Prospective, Multicenter Study To Evaluate the Performance and Safety of the Cerebroflo Evd Catheter · 2023 | Their institution | $7,080 |
| Orthofix Medical, Inc. · M6-C Pas · 2025 | Their institution | $5,016 |
| Orthofix Medical, Inc. · CA-C004 - M6-C Artificial Cervical Disc Ide Post Approval Study · 2024 | Their institution | $4,905 |
| Orthofix Medical, Inc. · M6-C Artificial Cervical Disc Ide Post Approval Study · 2023 | Their institution | $2,848 |
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 76.5 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1386701159
- Licence
- CA G39747California G39747: Current · expires 2027-04-30
- Trained
- University of Michigan Medical School, 1978
- Group
- Stanford Health Care
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- Yes
- Taxonomy
- Federal specialty code 207T00000X (207T00000X); Federal specialty code 2086S0102X (2086S0102X)
- Mailing address
- 3413 Ridgemont Dr, Mountain View, CA, 94040
- NPI first listed
- 2007-01-02
- NPI last updated
- 2024-04-26
- NPI record certified
- 2024-04-26
This is when the NPI record was last certified, not a medical board exam.